Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Recruiting
Sponsor: Psoriasis Treatment Center of Central New Jersey
Stay on Your Current Meds
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?4 weeks of adjunctive therapy of Enstilar® QD followed by 12 weeks QOD to patients with 2-10% BSA who are receiving etanercept or adalimumab for at least 24 weeks
Eligibility Criteria
Inclusion Criteria
Male or female adult ≥ 18 years of age;
Diagnosis of chronic plaque-type
Patient with 2-10% BSA
+2 more
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Open Label EnstilarExperimental Treatment1 Intervention
once daily for 4 weeks followed by QOD for 12 weeks for patients receiving Enbrel or Humira
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Psoriasis Treatment Center of Central New JerseyEast Windsor, NJ
Loading ...
Who Is Running the Clinical Trial?
Psoriasis Treatment Center of Central New JerseyLead Sponsor
LEO PharmaIndustry Sponsor